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The paper reviews the early stages of the research on natriuretic hormone. The described
experimental work was designed and accomplished in several internationally recognized
laboratories where the author was invited to extend his projects. The cross-circulation
experiments in animals with acutely increased extracellular fluid volume documented, that
in the mechanism of natriuresis – besides a series of the physical natriuretic factors –
there is still room for an active humoral natriuretic substance.This substance inhibited the
sodium transporting enzyme, Na,K-ATPase, in the frog skin. Analogous inhibition of the
renal Na,K-ATPase may be partly responsible for the increased sodium excretion. It was
further shown that the extent of natriuresis is positively modulated by the concentration
of sodium in the cerebrospinal fluid detected in the anterior-third ventricle region (AV3V) in
the brain.
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The first International “Symposium on Natriuretic Hormone” was
held at the Smolenice Castle, the Congress Center of the Slo-
vak Academy of Sciences in 1969, 12 years after the suggestion
of Homer Smith that some such factor could exist (1) and 8 years
since the first corroborative experimental data were presented by
the team of Hugh de Wardener (2). At the next symposium orga-
nized by the same Institution, a decade later we dealt rather with
“Natriuretic Hormones” (3). This review is a selected account on
the elaboration of the early stages of the hypothesis on the existence
of a natriuretic hormone in which I was privileged to participate.
CROSS-CIRCULATION EXPERIMENTS AND “rein au cou”
In the experiments of de Wardener et al. (2), evidence was
advanced for the transfer of a natriuretic material from the donor
dog with expanded extracellular fluid volume (ECFV) by the infu-
sion of saline to the cross-perfused recipient dog. The experiments
were arranged in such a way that the provoked natriuresis and
urine excretion in the recipient animal was neither a result of an
increase of the glomerular filtration rate nor of the decrease of
known circulating hormones, anti-natriuretic steroids, and vaso-
pressin. Consequently, a third factor was suggested to be involved.
Our group, in pursuing this provocative idea, modified the
cross-perfusion experiment in dogs. Only one kidney in situ in
the recipient dog was cross-perfused under constant perfusion
pressure by the donor’s blood in order to expose the recipient
kidney to a larger concentration of a natriuretic material than in
cross-perfusion of the whole animals. To prevent a possible natri-
uretic effect of blood dilution by saline infusion rather the blood
volume of the donor dog was expanded by an “artificial blood”
(suspension of homologous erythrocytes in 6% bovine albumin
in Ringer–Locke solution). The cross-perfused kidney increased
sodium and urine excretion following the blood volume expan-
sion of the donor dog. However, this “transferred natriuresis” was
less pronounced than natriuresis provoked by infusion of saline
in the previous experiment of de Wardener. It was concluded that
even if the natriuretic effect of blood dilution is eliminated the
cross-perfusion experiments may reveal the appearance of a natri-
uretic factor in blood of the donor dog following its blood volume
expansion (4). It was established in other experiments that the
bovine albumin in the “artificial blood” as such was not critical for
natriuresis evoked by blood volume expansion (5).
Yet, in another experimental set up, the homologous kidney
was transplanted to the neck of a dog (“rein au cou”) in which
vasopressin and creatinine were infused and DOCA was admin-
istered intramuscularly at least 3 h before the urine collection
started. Subsequently, the blood volume of the dog with the trans-
planted kidney was expanded by infusion of homologous blood.
The experimental conditions assured constant renal arterial and
venous pressures in the transplanted kidney, a constant plasma
oncotic pressure and constant hematocrit, glomerular filtration
rate, and renal blood flow. Moderate, when compared with the
renal output of the other kidney in situ, but significant increase
in urine output and sodium excretion was observed by the trans-
planted kidney. Since non-hormonal and hormonal factors mod-
ulating sodium and water excretion were kept under control in the
transplanted kidney, the results indicated more specifically than in
previous experiments that a natriuretic humoral material might
play a role in the mechanism of natriuresis provoked by blood
volume expansion (6).
The operation of a blood-borne natriuretic factor in rat cross-
circulation experiment was shown only when so-called sustained
fluid volume expansion was achieved by urine reinfusion in the
expanded donor animal. This procedure apparently intensified
the natriuretic signal to the recipient animal (7).
A NATRIURETIC OR A DILUTION OF AN ANTI-NATRIURETIC
SUBSTANCE?
Our next attempt was to challenge the question that emerged
from the cross-circulation experiments, namely, whether the
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appearance of a putative blood-borne natriuretic factor in ani-
mals with expanded ECFV was the result of an increased con-
centration of a natriuretic or a dilution of an anti-natriuretic
substance. The experiments were performed on un-anesthetized
cows, from which substantial volume of blood can be removed
without reversing the effect induced by the expansion of their
ECFV with 6% dextran in physiological saline (30 ml/kg b.w. at a
rate of 100 ml/min). A blood sample of 1000 ml was withdrawn
before the infusion and another one at the end of the infusion. The
deproteinized plasma was applied intravenously to the assay rats in
a volume of 0.2 ml. A non-significant tendency of control samples
rather to decrease both the rate of urine flow and sodium excretion
in the assay animals, was observed. On the other hand, the samples
withdrawn during the ECFV expansion in cows produced statisti-
cally significant increases in urine flow, sodium excretion, and the
tubular fractional sodium excretion in the assay rats. The sensi-
tivity of the biological assay (i.e., the natriuretic activity applied
in 0.2 ml of deproteinized plasma) might indicate that a separate
low-molecular weight natriuretic factor might be involved, and
that we are not dealing with a mere dilution effect of infusion on
an anti-natriuretic activity (8).
The same plasma sample also decreased the short-circuit cur-
rent representing active sodium transport in the frog skin by a
transporting enzyme Na,K-ATPase (9, 10). Buckalew et al. (11)
showed that an ultrafiltrate of blood from volume expanded dogs
inhibited sodium transport in the toad bladder. It may be another
indication for the presence of a natriuretic material in the tested
plasma sample as it was proposed that the renal mechanism of
natriuresis is via inhibition of the transporting enzyme in the
nephron (12).
Further elaboration of the concept of an endogenous inhibitor
of the Na,K-ATPase resulted in an attractive hypothesis linking
the inhibitor to digoxin-like activity found in some organs, blood,
and urine and to the pathogenesis of essential and low-renin arte-
rial hypertension (13–16). Indeed, it was subsequently found that
anti-digoxin serum decreased blood pressure in young rats with
DOCA-salt hypertension (17). The same anti-digoxin serum, how-
ever, was ineffective in suppressing natriuresis induced by ECFV
expansion with saline in rats (18). This finding illustrated at that
time that the number and nature of substances represented by
the endogenous digoxin-like activity had not been satisfactorily
answered (19–21), which is true even now.
INVOLVEMENT OF PERIPHERAL AND CENTRAL NERVOUS
SYSTEM IN THE SODIUM BALANCE
The reflex regulation of renal water excretion originating in the
stretch receptors of heart atria having the vagal nerves as the affer-
ent limb and vasopressin as an efferent limb (Gauer–Henry reflex)
was proposed to be applicable also to the mechanism of renal reg-
ulation of sodium excretion. The efferent limb of the reflex was
presumed to be a natriuretic factor produced in the brain. How-
ever, we found that natriuresis induced by infusion of artificial
blood in dogs with either innervated or denervated kidneys was
not abolished by bilateral vagotomy. Thus, the analogy of reflex
renal sodium control with a modified Gauer–Henry reflex did not
seem to be primarily at play (22). We, unfortunately, did not offer
at that time a more creative conclusion from these experiments.
It is obvious today that – 14 years before the discovery of atrial
natriuretic peptides – we missed a possibility to speculate about
the role of the heart as such in the renal sodium excretion during
the ECFV expansion. Our shortcoming in judgment was partly
due to the fact that others found the afferent signal to travel along
afferent sympathetic nerves and the spinal cord which, of course,
were not interrupted by vagotomy.
It has been shown in various species of anesthetized or con-
scious experimental animals that increased concentration or dilu-
tion of sodium salts in the cerebrospinal fluid (CSF) interfere,
respectively, with renal sodium excretion (23). In our studies on
conscious sheep, the increase in the CSF sodium concentration and
the simultaneous expansion of the ECFV resulted in a much higher
increase in renal sodium excretion in comparison to the effect of
ECFV expansion in animals with normal CSF sodium concen-
tration. Dilution of CSF sodium prevented completely natriuresis
following the ECFV expansion. This is thus another indication of
that the brain may be involved in the control of renal regulation
of ECFV by monitoring sodium concentration in CSF (24).
The periventricular organs that lack the blood–brain barrier
seem to be critical for changes in CSF and also in the systemic
ECF sodium concentration. A critical brain area where the sodium
concentration or osmolality is monitored is probably the anterior
wall of the third ventricle (AV3V). This conclusion is supported
by experiments in conscious sheep with ablated AV3V. The non-
lesioned control sheep were in a spontaneous water balance,
whereas water balance in the animals with chronically ablated
AV3V region was re-established by forced application of drink-
ing water through intrarumenal tube. It was found that ablation
of AV3V region blocks natriuresis to hypertonic but not isotonic
NaCl load provided the lesioned sheep is in water balance. McKin-
ley et al. (25, 26) suggested that the AV3V region has a role in
regulation of renal Na excretion in conditions where the plasma
Na concentration increases. It was further proposed that increased
renal Na excretion in response to hypernatremia is another cere-
brally mediated osmoregulatory response. However, the AV3V
region does not seem to be critical for the mechanism of natriuresis
induced by ECFV expansion with isotonic saline (24, 26, 27).
The posterior hypothalamus was also found to be involved in
the sodium and ECFV balance. Lesions in the posterior nucleus of
the hypothalamus are followed by a renal salt wasting syndrome in
rats, cats, and man. In both animal experiments and clinical cases,
it was shown that this type of negative sodium balance could not be
corrected by adrenal steroids. We tried to identify in rats whether
the nuclei in the posterior hypothalamus react to the disturbed
sodium balance. The rats were given only a 2% saline to drink for
10 days. A control group drank tap water. The hypothalami were
then sectioned and the volume of 200 cell nuclei was determined in
each animal of the following nuclei: posterior, ventromedialis, dor-
somedialis, and arcuate. The distribution of cell nuclear volume
size showed a statistically significant decrease only in the posterior
hypothalamic nucleus, which might suggest that it could have been
specifically influenced by increased sodium concentration in blood
and/or in CSF. At the time of this experiment, changes of volume
of cell nuclei in the nucleus posterior hypothalami were taken for
an indication of their neuroendocrine activity in connection with
salt loading (28, 29).
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CONCLUSION
Using modified cross-perfusion experiments, in which the blood
was not diluted, a methodology was put forward to exclude
the natriuretic effect of physical factors. It was confirmed that
during blood volume expansion a natriuretic or dilution of
anti-natriuretic material was revealed.
It was shown, in an attempt to isolate the presumed substance
playing a role in natriuresis following the blood or the whole ECF
volume expansion that it may be a substance with a natriuretic
activity.
The isolated substance also decreased the short-circuit current
in the frog skin, which is an indication for its potential to decrease
the activity of the transporting enzyme Na,K-ATPase. This action
of the natriuretic substance could be its contribution to the renal
mechanism of natriuresis following ECFV expansion.
It was shown in conscious sheep that the brain is involved in
the control of renal regulation of ECFV by monitoring sodium
concentration in CSF. A critical brain area, as indicated by others,
where the sodium concentration or osmolality is monitored is the
anterior wall of the third ventricle (AV3V).
Indirect evidence was presented for a neuroendocrine activity
of the nucleus posterior hypothalami related to the sodium balance
in rats.
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